These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16831985

  • 1. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis.
    Georgiadis D, Engelter S, Tettenborn B, Hungerbühler H, Luethy R, Müller F, Arnold M, Giambarba C, Baumann CR, von Büdingen HC, Lyrer P, Baumgartner RW.
    Circulation; 2006 Jul 18; 114(3):237-41. PubMed ID: 16831985
    [Abstract] [Full Text] [Related]

  • 2. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, Tarr RW, Selman WR, Landis DM, Suarez JI.
    J Stroke Cerebrovasc Dis; 2008 Sep 18; 17(5):266-72. PubMed ID: 18755405
    [Abstract] [Full Text] [Related]

  • 3. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC, Sung SF, Ong CT, Wu CS, Su YH.
    Acta Neurol Taiwan; 2009 Mar 18; 18(1):14-20. PubMed ID: 19537569
    [Abstract] [Full Text] [Related]

  • 4. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.
    Neurosurgery; 2009 Nov 18; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [Abstract] [Full Text] [Related]

  • 5. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A, Dzialowski I, Koch R, Gahn G.
    J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668
    [Abstract] [Full Text] [Related]

  • 6. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K, Iguchi Y, Shibazaki K, Kobayashi K, Uemura J, Aoki J, Yamashita S, Terasawa Y, Matsumoto N.
    J Neurol Sci; 2008 Jul 15; 270(1-2):48-52. PubMed ID: 18304581
    [Abstract] [Full Text] [Related]

  • 7. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ.
    Arch Neurol; 2008 May 15; 65(5):607-11. PubMed ID: 18332238
    [Abstract] [Full Text] [Related]

  • 8. Acute stroke management in the elderly.
    Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD.
    Cerebrovasc Dis; 2007 May 15; 23(4):304-8. PubMed ID: 17199089
    [Abstract] [Full Text] [Related]

  • 9. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH.
    J Stroke Cerebrovasc Dis; 2011 May 15; 20(2):124-30. PubMed ID: 20598579
    [Abstract] [Full Text] [Related]

  • 10. Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.
    Uchino K, Massaro L, Jovin TG, Hammer MD, Wechsler LR.
    J Stroke Cerebrovasc Dis; 2010 May 15; 19(6):417-23. PubMed ID: 21051004
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L, Sykora M, Gumbinger C, Herrmann O, Ringleb PA.
    Cerebrovasc Dis; 2012 May 15; 33(2):135-40. PubMed ID: 22179586
    [Abstract] [Full Text] [Related]

  • 12. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
    Köhrmann M, Nowe T, Huttner HB, Engelhorn T, Struffert T, Kollmar R, Saake M, Doerfler A, Schwab S, Schellinger PD.
    Cerebrovasc Dis; 2009 May 15; 27(2):160-6. PubMed ID: 19092237
    [Abstract] [Full Text] [Related]

  • 13. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y, Martí-Fàbregas J, Cocho D, Rodríguez-Yáñez M, Castellanos M, de la Ossa NP, Roquer J, Obach V, Maestre J, Martí-Vilalta JL.
    Cerebrovasc Dis; 2008 May 15; 26(2):126-33. PubMed ID: 18560215
    [Abstract] [Full Text] [Related]

  • 14. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM, Cleveland Clinic Health System Stroke Quality Improvement Team.
    Arch Neurol; 2004 Mar 15; 61(3):346-50. PubMed ID: 15023810
    [Abstract] [Full Text] [Related]

  • 15. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Mar 15; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 16. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
    Saposnik G, Demchuk A, Tu JV, Johnston SC, Stroke Outcomes Research Canada (SORCan) Working Group.
    J Stroke Cerebrovasc Dis; 2013 Aug 15; 22(6):876-82. PubMed ID: 23102741
    [Abstract] [Full Text] [Related]

  • 17. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
    Yoneda Y, Yamamoto S, Hara Y, Ohta K, Matsushita M, Yamamoto D, Yamashita H, Hosoda K.
    Clin Neurol Neurosurg; 2007 Sep 15; 109(7):567-70. PubMed ID: 17573188
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.